Edgepoint Investment Group INC Has Lowered Its Stake in Anthem INC (ANTM) as Valuation Rose

December 8, 2017 - By Marguerite Chambers

Edgepoint Investment Group Inc decreased its stake in Anthem Inc (ANTM) by 0.52% based on its latest 2017Q2 regulatory filing with the SEC. Edgepoint Investment Group Inc sold 11,614 shares as the company’s stock rose 10.08% with the market. The institutional investor held 2.22M shares of the health care company at the end of 2017Q2, valued at $417.80B, down from 2.23M at the end of the previous reported quarter. Edgepoint Investment Group Inc who had been investing in Anthem Inc for a number of months, seems to be less bullish one the $57.42 billion market cap company. The stock increased 0.42% or $0.93 during the last trading session, reaching $223.64. About 1.22M shares traded. Anthem, Inc. (NYSE:ANTM) has risen 31.86% since December 8, 2016 and is uptrending. It has outperformed by 15.16% the S&P500.

Edgepoint Investment Group Inc, which manages about $6.32B US Long portfolio, upped its stake in Aegerion Pharmaceuticals Inc. by 9.00M shares to 42.64 million shares, valued at $35.02 billion in 2017Q2, according to the filing. It also increased its holding in Jpmorgan Chase & Co (NYSE:JPM) by 213,443 shares in the quarter, for a total of 1.19M shares, and has risen its stake in Affiliated Managers Group (NYSE:AMG).

Analysts await Anthem, Inc. (NYSE:ANTM) to report earnings on February, 7. They expect $1.25 EPS, down 28.98 % or $0.51 from last year’s $1.76 per share. ANTM’s profit will be $320.95 million for 44.73 P/E if the $1.25 EPS becomes a reality. After $2.65 actual EPS reported by Anthem, Inc. for the previous quarter, Wall Street now forecasts -52.83 % negative EPS growth.

More notable recent Anthem, Inc. (NYSE:ANTM) news were published by: Businesswire.com which released: “AM Best Assigns Indicative Issue Credit Ratings to Anthem, Inc.’s New Shelf …” on December 04, 2017, also Globenewswire.com with their article: “Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation” published on November 13, 2017, Nasdaq.com published: “Anthem, Inc. (ANTM) Ex-Dividend Date Scheduled for December 04, 2017” on December 01, 2017. More interesting news about Anthem, Inc. (NYSE:ANTM) were released by: Businesswire.com and their article: “AM Best Assigns Issue Credit Ratings to Anthem, Inc.’s Forthcoming Senior …” published on November 15, 2017 as well as Businesswire.com‘s news article titled: “Anthem Announces Pricing of Its Tender Offer for Notes due 2034, 2036, 2037 …” with publication date: November 29, 2017.

Anthem, Inc. (NYSE:ANTM) Ratings Coverage

Among 23 analysts covering Anthem Inc (NYSE:ANTM), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Anthem Inc had 61 analyst reports since July 27, 2015 according to SRatingsIntel. Leerink Swann maintained Anthem, Inc. (NYSE:ANTM) on Tuesday, November 7 with “Outperform” rating. The firm has “Buy” rating given on Monday, July 27 by Sterne Agee CRT. As per Thursday, June 16, the company rating was initiated by Bernstein. The company was maintained on Thursday, January 28 by RBC Capital Markets. The firm has “Neutral” rating given on Wednesday, January 4 by Piper Jaffray. RBC Capital Markets maintained Anthem, Inc. (NYSE:ANTM) on Thursday, July 30 with “Outperform” rating. The firm earned “Outperform” rating on Thursday, October 29 by RBC Capital Markets. RBC Capital Markets maintained the shares of ANTM in report on Wednesday, July 5 with “Buy” rating. The stock of Anthem, Inc. (NYSE:ANTM) earned “Outperform” rating by Oppenheimer on Thursday, July 30. Wells Fargo upgraded the stock to “Outperform” rating in Tuesday, November 15 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.